Discovery of orally active indirubin-3′-oxime derivatives as potent type 1 FLT3 inhibitors for acute myeloid leukemia
Pyeonghwa Jeong(Gwangju Institute of Science and Technology), Yoon-Gyoon Kim(Gwangju Institute of Science and Technology), Jungil Choi(Korea Institute of Toxicology), Yeongyu Moon(Korea Institute of Toxicology), So‐Deok Lee(Gwangju Institute of Science and Technology), Sun‐Young Han(University of Colorado Health), Hyun Woo Park(Yonsei University), Jiheon Kim(Seoul National University), Jeong‐Doo Heo(Korea Institute of Toxicology), Ji Eun Shin(Yonsei University), Yong‐Chul Kim(Gwangju Institute of Science and Technology), Jung-Eun Lee(Gwangju Institute of Science and Technology), Jiyeon Park(Gwangju Institute of Science and Technology), Na Yoon Kim(Dankook University), Je‐Heon Lee(Gwangju Institute of Science and Technology), Hyo‐Jeong Lee(Kyung Hee University)
Cited by 29
Related Papers
Atomic-level tuning of Co–N–C catalyst for high-performance electrochemical H2O2 production
|Nature Materials|2020|1.2k
Dynamic Regulation of CFTR Bicarbonate Permeability by [Cl−]i and Its Role in Pancreatic Bicarbonate Secretion
|Gastroenterology|2010|193
Pectolinarigenin Induced Cell Cycle Arrest, Autophagy, and Apoptosis in Gastric Cancer Cell via PI3K/AKT/mTOR Signaling Pathway
|Nutrients|2018|136
Naringin induces autophagy-mediated growth inhibition by downregulating the PI3K/Akt/mTOR cascade via activation of MAPK pathways in AGS cancer cells
|International Journal of Oncology|2015|101